BHC
HEALTHCAREBausch Health Companies Inc
AI Insight
What's Moving BHC Today?
No stock-specific AI insight has been generated for BHC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.57$8.69
$4.80
Fundamentals
Market Cap$1.7B
P/E Ratio—
EPS$-3.24
Dividend Yield—
Dividend / Share—
ROE43.6%
Profit Margin-11.5%
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding373.5M
BHC News
23 articles- Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophreniaNewswire Canada·Jun 9, 2026
- Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?Yahoo Finance·May 29, 2026
- Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in ChinaYahoo Finance·May 28, 2026
- Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark PharmaceuticalsYahoo Finance·May 21, 2026
- Shareholders of Bausch Health (NYSE: BHC) approve directors, pay and PwCStock Titan·May 20, 2026
- Bausch Health Announces 2026 Annual Meeting of Shareholder ResultsYahoo Finance·May 19, 2026
- Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy GrowthYahoo Finance·May 18, 2026
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare ConferenceYahoo Finance·May 13, 2026
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance ConferenceYahoo Finance·May 12, 2026
- Why Bausch Health Companies Was Crawling Higher This WeekThe Motley Fool·May 1, 2026
- TSX up 455 Points at Midday With Healthcare, Materials, The Best PerformersYahoo Finance·Apr 30, 2026
- BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta StrengthYahoo Finance·Apr 30, 2026
- Bausch Health Companies Inc. Q1 2026 Earnings Call SummaryMoby·Apr 30, 2026
- Bausch Health Companies Inc (BHC) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Apr 30, 2026
- Bausch + Lomb Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Bausch Health Cos Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Bausch Health (BHC) Lags Q1 Earnings EstimatesYahoo Finance·Apr 30, 2026
- Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key MetricsYahoo Finance·Apr 30, 2026
- Bausch Health (BHC) Q1 2026 Earnings TranscriptMotley Fool·Apr 29, 2026
- Bausch Health Q1 Adjusted Earnings, Revenue, Advance, Beating EstimatesYahoo Finance·Apr 29, 2026
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTSYahoo Finance·Apr 29, 2026
- Pheochromocytoma and Paraganglioma Market to Exhibit Growth at 7.3% CAGR by 2036 Driven by the Advent of Drug Classes Such as SSTR2 analogs, Dopamine Receptor D2 Agonists, TAAs or TSAs, and Others | DelveInsightGlobeNewswire Inc.·Apr 20, 2026
- Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic DemandGlobeNewswire Inc.·Apr 13, 2026
All 23 articles loaded
Price Data
Open$4.69
Previous Close$4.80
Day High$4.80
Day Low$4.67
52 Week High$8.69
52 Week Low$4.57
52-Week Range
$4.57$8.69
$4.80
Fundamentals
Market Cap$1.7B
P/E Ratio—
EPS$-3.24
Dividend Yield—
Dividend / Share—
ROE43.6%
Profit Margin-11.5%
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding373.5M
About Bausch Health Companies Inc
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—